Kwality Pharmaceuticals: our biggest position in portfolio, the best quarter in its history, and a Big Four auditor to sign the next one
We have been buying this share in instalments, adding on upward moves and on reasonable corrections. We now hold 653 shares at an average cost of ₹2,482.78 which represents 11.9% of our total model portfolio
Read more